MENU
+Compare
CNVVY
Stock ticker: OTC
AS OF
Dec 1 closing price
Price
$12.53
Change
+$0.02 (+0.16%)
Capitalization
6.1B

CNVVY ConvaTec Group plc Forecast, Technical & Fundamental Analysis

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings... Show more

CNVVY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CNVVY with price predictions
Dec 01, 2025

CNVVY in -0.64% downward trend, declining for three consecutive days on November 28, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CNVVY declined for three days, in of 127 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNVVY as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CNVVY moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNVVY crossed bearishly below the 50-day moving average on November 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for CNVVY entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where CNVVY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNVVY just turned positive on November 28, 2025. Looking at past instances where CNVVY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNVVY advanced for three days, in of 113 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNVVY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.382) is normal, around the industry mean (9.251). P/E Ratio (29.552) is within average values for comparable stocks, (163.356). Projected Growth (PEG Ratio) (1.567) is also within normal values, averaging (2.549). Dividend Yield (0.022) settles around the average of (0.016) among similar stocks. P/S Ratio (2.732) is also within normal values, averaging (110.799).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNVVY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CNVVY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

CNVVY paid dividends on October 16, 2025

ConvaTec Group plc CNVVY Stock Dividends
А dividend of $0.07 per share was paid with a record date of October 16, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
20 Eastbourne Terrace
Phone
+44 7826447807
Employees
10129
Web
https://www.convatecgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADCIX26.94N/A
N/A
American Century Disciplined Growth I
LAMAX26.06N/A
N/A
Lord Abbett Dividend Growth A
GMVAX17.28N/A
N/A
Goldman Sachs Small/Mid Cap Equity A
BDHAX8.96-0.03
-0.33%
BlackRock Dynamic High Income Inv A
GAFFX88.81-0.66
-0.74%
American Funds Growth Fund of Amer F3

CNVVY and Stocks

Correlation & Price change

A.I.dvisor tells us that CNVVY and CRL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and CRL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.17%
CRL - CNVVY
26%
Poorly correlated
-1.15%
TWST - CNVVY
26%
Poorly correlated
-6.72%
KIDS - CNVVY
24%
Poorly correlated
-2.76%
CLPBY - CNVVY
24%
Poorly correlated
-1.20%
CZMWY - CNVVY
23%
Poorly correlated
-2.86%
More

Groups containing CNVVY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
+0.17%
Pharmaceuticals
category (377 stocks)
26%
Poorly correlated
-0.56%
Pharmaceuticals: Other
category (103 stocks)
21%
Poorly correlated
-0.87%